Industrial

Pfizer has leapt to the top of the most active corporate venturing investors in US healthcare deals for the first half of 2016, as Novartis falls out of the top 10.

BP, ConocoPhillips and LeFrak all exited microbiome product developer Taxon Biosciences in an acquisition by DuPont.

Second Genome, which is applying genomics technology to the microbiome, is the latest in a growing string of gene technology companies to raise substantial funding.

The electronics producer will seek startups developing technology that can be used for home appliances, work and more advanced equipment, for a Japan-based accelerator.

As the Indian Institute of Management Ahmedabad's Infuse Ventures fund nears full deployment, the institution prepares to launch the $150m Bharat Innovations Fund.

Air Liquide and Maire Tecnimont have joined NatPet for a series E round that took the amount raised by the gas-to-fuel company to $170m since 2008.

Oyo Rooms has raised $61.3m from existing investors likely to include SoftBank, as it looks to expand its branded budget hotel experience across India and into adjacent sectors.

The week's review of venturing activity across our three titles, Global Corporate Venturing, Global University Venturing and Global Government Venturing.

Quarterly analysis: The is a snapshot of the data we have collected on investment activity over the past three months. To cross-check and double-check details of reported deals, we have contacted a large number of corporate investors around the world.